Pharma Holdings

Pharma Holdings

Private
Oslo, OsloHealthcare & Life Scienceshttp://www.pharmaholdings.no

Last Round

VC Round

Dec 22, 2023

Company Overview

Pharma Holdings AS is a privately owned, clinical-stage pharmaceutical company with offices in Oslo and Tromsø, Norway. Founded in 2017 as a spin-off from Lytix Biopharma AS, the company's goal is to become a significant provider of antimicrobials. Its lead compound, LTX-109, is an investigational drug with a novel membrane-lysing mechanism for treating skin conditions and for nasal decolonization. The company operates a lean business model, utilizing a network of contract research organizations and experienced advisors for its development and clinical trials.

Sector

Healthcare & Life Sciences

Verticals

Clinical Trials, Drug Discovery, Biotechnology

Business Model

B2B

Customer Profile

Revenue Share, Government Contracts

AI Layer

Non-AI

Keywords

antimicrobial nasal sprayLTX-109antimicrobial drugsrespiratory viral infectionsantimicrobial peptidesvirtual pharmadrug licensingclinical-stage biotechcontract research organizationCROcontract development and manufacturing organizationCDMOmembrane-lysing mechanismvirucidal effect

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Pharma Holdings Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Pharma Holdings Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
VC RoundDec 22, 2023
VC RoundDec 16, 2022

Pharma Holdings Investors

Notable investors and investment history

InvestorRounds
Picasso VenturesVC Round
AleapVC Round
Norinnova InvestVC Round

Pharma Holdings Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Pharma Holdings Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Pharma Holdings's valuation, stock price, and market status.

Firmographic Details

HeadquartersOslo, Oslo
Year Founded2016
Last FundingDec 22, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.